BIOCHEMICAL, CLINICAL, AND GENETIC FEATURES OF TYPE-III HYPERLIPOPROTEINEMIA

被引：251

作者：

MORGANROTH, J ^{[1
]}

LEVY, RI ^{[1
]}

FREDRICKSON, DS ^{[1
]}

机构：

[1] NHLI, MOLEC DIS BRANCH, BETHESDA, MD 20014 USA

来源：

关键词：

D O I：

10.7326/0003-4819-82-2-158

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：158 / 174

页数：17

共 34 条

[11] FREDRICKSON DS, 1972, METABOLIC BASIS INHE, P545
[12] IMMUNOREACTIVE INSULIN, GLUCOSE TOLERANCE, AND CARBOHYDRATE INDUCIBILITY IN TYPES 2, 3, 4, AND V HYPERLIPOPROTEINEMIA
GLUECK, CJ
LEVY, RI
FREDRICKSON, DS
[J]. DIABETES, 1969, 18 (11) : 739 - +
[13] GOCHMAN N, 1972, CLIN CHEM, V18, P943
[14] GOCHMAN N, 1971, CLIN CHEM, V17, P1154
[15] GODOLPHIN WJ, 1972, LANCET, V1, P209
[16] GOFMAN JOHN W., 1954, PLASMA [MILAN], V2, P413
[17] HALL M, 1974, CIRCULATION S3, V50, P449
[18] PRIMARY DYSBETA-LIPOPROTEINEMIA - PREDOMINANCE OF A SPECIFIC APOPROTEIN SPECIES IN TRIGLYCERIDE-RICH LIPOPROTEINS
HAVEL, RJ
KANE, JP
[J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1973, 70 (07) : 2015 - 2019
[19] ABNORMAL LIPID COMPOSITION OF VERY LOW-DENSITY LIPOPROTEINS IN DIAGNOSIS OF BROAD-BETA DISEASE (TYPE-III HYPERLIPOPROTEINEMIA)
HAZZARD, WR
BIERMAN, EL
PORTE, D
[J]. METABOLISM-CLINICAL AND EXPERIMENTAL, 1972, 21 (11): : 1009 - +
[20] HOLIMON JL, 1971, ARCH PATHOL, V92, P415